Diane E. Handy

NetMedGPT is a transformer-based foundation model trained on biomedical knowledge graphs to predict drug-disease associations and support drug repurposing, outperforming specialized models in multiple tasks.

DREAMER identifies molecular mechanisms of adverse drug reactions and disease phenotypes using network-based analysis, revealing key proteins and pathways involved in various conditions.